BIOLASE REPORTS CONTINUED GROWTH FOR FOURTH QUARTER AND FULL YEAR 2021

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. AVGO
3. CDNS
4. SPY
5. ANT
6. META
7. BA
8. INTC
9. JBLU
10. AAPL

Go back to BIOLASE REPORTS CONTINUED GROWTH FOR FOURTH QUARTER AND FULL YEAR 2021

Biolase (BIOL) Reports Q4 EPS of ($0.03)

March 17, 2022 4:11 PM EDT

Biolase (NASDAQ: BIOL) reported Q4 EPS of ($0.03). Revenue for the quarter came in at $12.4 million versus the consensus estimate of $11.97 million.

For earnings history and earnings-related data on Biolase (BIOL) click here.

... More